News
AstraZeneca has announced positive high-level results from its Phase III KALOS and LOGOS trials, showing significant promise ...
Zacks Investment Research on MSN2h
Pharma Stock Roundup: NVO & JAZZ's Q1 Results, AZN's Pipeline UpdateNovo Nordisk NVO and Jazz Pharmaceuticals JAZZ reported their first-quarter results. AstraZeneca’s AZN late-stage asthma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback